ArticleJournal of food and drug analysis2024
Cost-effectiveness analysis of pembrolizumab with chemotherapy for metastatic nonsquamous non-small cell lung cancer in Taiwan.
Wei-Ling Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.